Ocular penetration of caspofungin in a rabbit uveitis model

Goldblum, David; Fausch, Kathrin; Frueh, Beatrice E; Theurillat, Regula; Thormann, Wolfgang; Zimmerli, Stefan (2007). Ocular penetration of caspofungin in a rabbit uveitis model. Graefe's archive for clinical and experimental ophthalmology, 245(6), pp. 825-833. Berlin: Springer-Verlag 10.1007/s00417-006-0460-x

[img]
Preview
Text
417_2006_Article_460.pdf - Published Version
Available under License Publisher holds Copyright.

Download (202kB) | Preview

BACKGROUND: Little is known about the ocular penetration of echinocandin antifungals. We studied the ocular distribution of systemically administered caspofungin in a rabbit uveitis model. METHODS: Caspofungin (1 mg/kg per day) was given intravenously to rabbits as a single dose or as repeated daily doses on 7 days starting 24 h after induction of unilateral uveitis by intravitreal endotoxin injection. Caspofungin concentrations were determined by high-performance liquid chromatography in the cornea, aqueous humor, vitreous humor, and serum 4, 8, 16, and 24 h after administration of a single dose and 24 h after the last of seven doses. RESULTS: The mean caspofungin concentration in the aqueous of the inflamed eye 4 and 8 h after single-dose administration was 1.30 +/- 0.39 mug/ml and 1.12 +/- 0.34 mug/ml, respectively. Drug concentrations decreased to 0.24 +/- 0.09 mug/ml at 16 h and 0.26 +/- 0.14 mug/ml at 24 h. In the vitreous of inflamed eyes drug levels were undetectable at all time points. No drug was found in the aqueous of inflamed eyes 24 h after the last of seven repeated doses, and the vitreous only contained trace amounts. In the corneas of inflamed eyes concentrations reached 1.64 +/- 0.48 mug/g at 4 h, peaked at 2.16 +/- 1.14 mug/g at 8 h, and declined to 1.87 +/- 0.52 mug/g and 1.49 +/- 0.48 mug/g at 16 and 24 h, respectively. After repeated dosing, corneal concentrations of caspofungin were 0.8 and 1.0 mug/g and below the limit of detection in two of four animals. In non-inflamed eyes no drug was detectable in the aqueous and vitreous humor, and the corneas at any time point. CONCLUSIONS: In our model, caspofungin reached therapeutically relevant levels in the aqueous and cornea but not in the vitreous humor of inflamed eyes. Intraocular drug deposition was critically dependent on a disrupted blood-eye barrier. These findings suggest a limited role for caspofungin in the treatment of fungal endophthalmitis.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Ophthalmology
04 Faculty of Medicine > Service Sector > Institute of Clinical Pharmacology and Visceral Research (discontinued)
04 Faculty of Medicine > Service Sector > Institute for Infectious Diseases

UniBE Contributor:

Goldblum, David; Früh Epstein, Beatrice; Theurillat, Regula; Thormann, Wolfgang and Zimmerli, Stefan

ISSN:

0721-832X

ISBN:

17120004

Publisher:

Springer-Verlag

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:45

Last Modified:

25 Oct 2019 01:47

Publisher DOI:

10.1007/s00417-006-0460-x

PubMed ID:

17120004

Web of Science ID:

000246594000009

BORIS DOI:

10.7892/boris.18569

URI:

https://boris.unibe.ch/id/eprint/18569 (FactScience: 761)

Actions (login required)

Edit item Edit item
Provide Feedback